Journal
JCI Insight
Publication Date
1-23-2024
Volume
9
Issue
2
First Page
e175785
Document Type
Open Access Publication
DOI
10.1172/jci.insight.175785
Rights and Permissions
Barrios EL, Mazer MB, McGonagill PW, Bergmann CB, Goodman MD, Gould RW, Rao M, Polcz VE, Davis RJ, Del Toro DE, Dirain ML, Dram A, Hale LO, Heidarian M, Kim CY, Kucaba TA, Lanz JP, McCray AE, Meszaros S, Miles S, Nelson CR, Rocha IL, Silva EE, Ungaro RF, Walton AH, Xu J, Zeumer-Spataro L, Drewry AM, Liang M, Bible LE, Loftus TJ, Turnbull IR, Efron PA, Remy KE, Brakenridge SC, Badovinac VP, Griffith TS, Moldawer LL, Hotchkiss RS, Caldwell CC. Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot. JCI Insight. 2024 Jan 23;9(2):e175785. doi: 10.1172/jci.insight.175785. © 2024, Barrios et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Barrios, Evan L.; Del Toro, Drew E.; Dram, Alexandra; Meszaros, Sandra; Miles, Sydney; Walton, Andrew H.; Drewry, Anne M.; Turnbull, Isaiah R.; Hotchkiss, Richard S; and et al., "Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot." JCI Insight. 9, 2. e175785 (2024).
https://digitalcommons.wustl.edu/oa_4/3067
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
